Medication Monitor

Generic Name (Trade Name—Company)
June 20, 2011


(generics—Multiple companies)
First generic versions approved


Treatment of susceptible bacterial infections

FDA announced that the first generic versions of levofloxacin tablets, oral solution, and injectable solution have been approved. Twelve manufacturers have approved applications for levofloxacin: Akorn, Aurobindo Pharma, Dr. Reddy’s Laboratories, Glenmark Generics, Hi-Tech Pharmacal, Lupin, Mylan, Sagent Strides, Sandoz, Teva, Torrent, and Wockhardt. The drug is indicated for the treatment of susceptible bacterial infections including acute sinusitis, acute exacerbations of chronic bronchitis, nosocomial or community-acquired pneumonia, urinary tract infections, acute pyelonephritis, chronic bacterial prostatitis, and skin and skin structure infections. Levofloxacin is also indicated to reduce incidence or progression of disease following exposure to inhalational anthrax.